Daesung Microbiological Labs. Co., Ltd. (KOSDAQ: 036480)
South Korea
· Delayed Price · Currency is KRW
10,030
+40 (0.40%)
Oct 10, 2024, 9:00 AM KST
Daesung Microbiological Labs. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -2,602 | -679.68 | 1,703 | 865.92 | 1,519 | 2,471 | Upgrade
|
Depreciation & Amortization | 2,850 | 2,862 | 2,706 | 2,538 | 1,948 | 1,110 | Upgrade
|
Loss (Gain) From Sale of Assets | -9.44 | 0.07 | -2,219 | -7 | -11.72 | -11.71 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | 274.54 | - | Upgrade
|
Loss (Gain) From Sale of Investments | 0.29 | 0.29 | 0.91 | 0.3 | 0.12 | 0.23 | Upgrade
|
Loss (Gain) on Equity Investments | 40.86 | -36.39 | 14.6 | 4.97 | - | - | Upgrade
|
Provision & Write-off of Bad Debts | 40.84 | 27.09 | 29.42 | 12.07 | 116.72 | -18.01 | Upgrade
|
Other Operating Activities | 351.01 | -342.66 | 881.17 | 367.84 | 939.73 | 112.95 | Upgrade
|
Change in Accounts Receivable | -453.96 | -1,130 | -103.07 | 516.13 | -809.4 | 930.78 | Upgrade
|
Change in Inventory | 255.24 | -1,132 | -1,027 | -1,417 | 69.22 | -1,337 | Upgrade
|
Change in Accounts Payable | 211.42 | 565.26 | 209.1 | -468.3 | -575.83 | -34.92 | Upgrade
|
Change in Other Net Operating Assets | -819.72 | -1,368 | -1,039 | -209.63 | -233.28 | -907.4 | Upgrade
|
Operating Cash Flow | -136.18 | -1,234 | 1,155 | 2,203 | 3,236 | 2,315 | Upgrade
|
Operating Cash Flow Growth | - | - | -47.56% | -31.92% | 39.77% | -26.18% | Upgrade
|
Capital Expenditures | -975.62 | -1,256 | -2,315 | -2,968 | -14,006 | -11,439 | Upgrade
|
Sale of Property, Plant & Equipment | 11.82 | 59.09 | 4,572 | 7 | 24.09 | 23.59 | Upgrade
|
Sale (Purchase) of Intangibles | -3.84 | -3.96 | -0.39 | -0.8 | -437.9 | -135.84 | Upgrade
|
Investment in Securities | 4,014 | 1,437 | -3,415 | -678.96 | -1,152 | 1,787 | Upgrade
|
Other Investing Activities | 0 | - | 0 | 0 | -0 | - | Upgrade
|
Investing Cash Flow | 3,046 | 235.73 | -1,158 | -3,641 | -15,572 | -9,764 | Upgrade
|
Short-Term Debt Issued | - | 3,319 | 2,000 | 700 | 700 | - | Upgrade
|
Long-Term Debt Issued | - | 3,000 | - | 800 | 10,050 | 11,143 | Upgrade
|
Total Debt Issued | 1,319 | 6,319 | 2,000 | 1,500 | 10,750 | 11,143 | Upgrade
|
Short-Term Debt Repaid | - | - | -700 | -700 | -700 | - | Upgrade
|
Long-Term Debt Repaid | - | -4,553 | -1,661 | -172.18 | -168.81 | -125 | Upgrade
|
Total Debt Repaid | -5,542 | -4,553 | -2,361 | -872.18 | -868.81 | -125 | Upgrade
|
Net Debt Issued (Repaid) | -4,224 | 1,766 | -361.29 | 627.82 | 9,881 | 11,018 | Upgrade
|
Dividends Paid | -285 | -285 | -285 | -323 | -323 | -323 | Upgrade
|
Other Financing Activities | - | - | - | -0 | - | - | Upgrade
|
Financing Cash Flow | -4,509 | 1,481 | -646.29 | 304.82 | 9,558 | 10,695 | Upgrade
|
Foreign Exchange Rate Adjustments | 92.49 | 28.2 | 105.91 | 316.07 | -262.8 | 63.17 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | 0 | 0 | - | Upgrade
|
Net Cash Flow | -1,507 | 510.68 | -543.44 | -816.59 | -3,040 | 3,309 | Upgrade
|
Free Cash Flow | -1,112 | -2,490 | -1,160 | -764.71 | -10,770 | -9,123 | Upgrade
|
Free Cash Flow Margin | -4.63% | -9.74% | -4.55% | -3.19% | -43.43% | -36.30% | Upgrade
|
Free Cash Flow Per Share | -292.32 | -655.25 | -305.03 | -200.47 | -2836.73 | -2399.78 | Upgrade
|
Cash Interest Paid | 1,037 | 955.25 | 458.48 | 271.46 | 2.85 | 2.8 | Upgrade
|
Cash Income Tax Paid | 133.23 | 475.4 | 46.03 | -94.73 | 187.82 | 588.27 | Upgrade
|
Levered Free Cash Flow | 26.37 | -1,862 | -997.53 | -1,065 | -12,016 | -8,889 | Upgrade
|
Unlevered Free Cash Flow | 616.18 | -1,304 | -677.16 | -891.44 | -12,009 | -8,880 | Upgrade
|
Change in Net Working Capital | -456.44 | 2,476 | 862.75 | 671.53 | 711.13 | 527.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.